Related Experiment Video
Updated: Jan 18, 2026

05:45
Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections
Published on: July 31, 2017
10.1K
Oncogenic drivers shape the tumor microenvironment in human gliomas
Biorxiv : the Preprint Server for Biology
|June 6, 2025
Summary
Genomic alterations in gliomas shape their microenvironment. IDH-mutant gliomas show specific microglia, while glioblastomas have more T-cells and immunosuppressive myeloid cells.
Area of Science:
- Neuro-oncology
- Genomics
- Cancer Biology
Background:
- Gliomas are aggressive brain tumors with poorly understood tumor microenvironments.
- Oncogenic mutations significantly impact glioma progression but their influence on the microenvironment is unclear.
Purpose of the Study:
- To investigate how genomic alterations influence the glioma microenvironment.
- To define the impact of major driver mutations on spatial tumor organization.
Main Methods:
- Integrative multiomic and spatial transcriptomic analysis of 93 glioma samples.
- Whole-genome sequencing, Hi-C, RNA-seq, and Xenium single-cell spatial transcriptomics were employed.
- Comparison of IDH-mutant gliomas and IDH-wildtype glioblastomas, including analysis of EGFR amplification modes (ecDNA vs. linear).
Main Results:
- IDH-mutant gliomas exhibited inflammatory microglia (CX3CR1+) in astrocyte-like malignant neighborhoods.
- Glioblastomas showed increased T-cell infiltration and immunosuppressive myeloid cells.
- EGFR ecDNA-driven glioblastomas displayed mesenchymal-like cells and increased pericyte-malignant cell interactions, linked to hypoxia and vascular proliferation.
Conclusions:
- The mode of oncogene amplification (linear vs. ecDNA) dictates distinct glioma architectures and transcriptional dynamics.
- Oncogenic drivers significantly shape the glioma microenvironment, creating subtype-specific cellular ecosystems.
- Findings provide insights for developing targeted therapeutic strategies for gliomas.
More Related Videos
Related Concept Videos
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Cancer-Critical Genes I: Proto-oncogenes
11.2K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.2K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Cancers Originate from Somatic Mutations in a Single Cell
14.6K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.6K
Induced Pluripotent Stem Cells
5.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.4K
Cancer Stem Cells and Tumor Maintenance
5.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.9K

